233 related articles for article (PubMed ID: 10064973)
1. [Factors that influence the serum of atrial natriuretic peptide and brain natriuretic peptide concentrations--is there a specific marker for senile patients?].
Sayama H; Nakamura Y; Saitou N; Doi Y; Matsukura S; Sakurai H; Kinoshita M
Nihon Ronen Igakkai Zasshi; 1998 Nov; 35(11):851-7. PubMed ID: 10064973
[TBL] [Abstract][Full Text] [Related]
2. The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation.
Bakowski D; Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2009 Apr; 67(4):361-7. PubMed ID: 19492248
[TBL] [Abstract][Full Text] [Related]
3. The influence of left ventricle diastolic function on natriuretic peptides levels in patients with atrial fibrillation.
Bakowski D; Wozakowska-Kaplon B; Opolski G
Pacing Clin Electrophysiol; 2009 Jun; 32(6):745-52. PubMed ID: 19545336
[TBL] [Abstract][Full Text] [Related]
4. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic potential of cardiac natriuretic peptides in dialysis patients.
Mallamaci F; Zoccali C; Tripepi G; Benedetto FA; Parlongo S; Cataliotti A; Cutrupi S; Giacone G; Bellanuova I; Stancanelli B; Malatino LS;
Kidney Int; 2001 Apr; 59(4):1559-66. PubMed ID: 11260421
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Vuolteenaho O; Hartikainen J
J Intern Med; 2002 Mar; 251(3):228-34. PubMed ID: 11886482
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation.
Shimamoto K; Kusumoto M; Sakai R; Watanabe H; Ihara S; Koike N; Kawana M
Can J Cardiol; 2007 Mar; 23(4):295-300. PubMed ID: 17380223
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic peptides as markers of preclinical cardiac disease in obesity.
Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A
Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331
[TBL] [Abstract][Full Text] [Related]
9. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
Yamamoto K; Burnett JC; Jougasaki M; Nishimura RA; Bailey KR; Saito Y; Nakao K; Redfield MM
Hypertension; 1996 Dec; 28(6):988-94. PubMed ID: 8952587
[TBL] [Abstract][Full Text] [Related]
10. [Plasma cardiac natriuretic peptide as a biological marker of recurrence of atrial fibrillation in elderly people].
Mabuchi N; Tsutamoto T; Maeda K; Masahiko K
Nihon Ronen Igakkai Zasshi; 2000 Jul; 37(7):535-40. PubMed ID: 11031826
[TBL] [Abstract][Full Text] [Related]
11. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.
Yu CM; Sanderson JE; Shum IO; Chan S; Yeung LY; Hung YT; Cockram CS; Woo KS
Eur Heart J; 1996 Nov; 17(11):1694-702. PubMed ID: 8922918
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic potential of circulating natriuretic peptides in chronic kidney disease.
Mark PB; Stewart GA; Gansevoort RT; Petrie CJ; McDonagh TA; Dargie HJ; Rodger RS; Jardine AG
Nephrol Dial Transplant; 2006 Feb; 21(2):402-10. PubMed ID: 16221702
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of plasma atrial and brain natriuretic peptide levels during hemodialysis in hemodialysis patients with old myocardial infarction].
Uetake S; Takahashi M; Tamano K; Honda T; Kobayashi T; Horinaka S
J Cardiol; 2001 Aug; 38(2):61-71. PubMed ID: 11525111
[TBL] [Abstract][Full Text] [Related]
14. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
[TBL] [Abstract][Full Text] [Related]
15. Associations between plasma natriuretic peptides and echocardiographic abnormalities in geriatric outpatients.
Rutten JH; van der Velde N; van der Cammen TJ; ten Cate FJ; Vletter WB; Boomsma F; van den Meiracker AH
Arch Gerontol Geriatr; 2008; 47(2):189-99. PubMed ID: 17900714
[TBL] [Abstract][Full Text] [Related]
16. Left atrial size by planimetry is superior to M-mode diameter: biochemical calibration by atrial and brain natriuretic peptide.
Buchner S; Muscholl M; Debl K; Hense HW; Döring A; Stritzke J; Schunkert H; Jougasaki M; Burnett JC; Riegger GA; Luchner A
J Am Soc Echocardiogr; 2008 Apr; 21(4):380-5. PubMed ID: 17681726
[TBL] [Abstract][Full Text] [Related]
17. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study.
Rossi A; Enriquez-Sarano M; Burnett JC; Lerman A; Abel MD; Seward JB
J Am Coll Cardiol; 2000 Apr; 35(5):1256-62. PubMed ID: 10758968
[TBL] [Abstract][Full Text] [Related]
18. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
[TBL] [Abstract][Full Text] [Related]
19. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.
Cataliotti A; Malatino LS; Jougasaki M; Zoccali C; Castellino P; Giacone G; Bellanuova I; Tripepi R; Seminara G; Parlongo S; Stancanelli B; Bonanno G; Fatuzzo P; Rapisarda F; Belluardo P; Signorelli SS; Heublein DM; Lainchbury JG; Leskinen HK; Bailey KR; Redfield MM; Burnett JC
Mayo Clin Proc; 2001 Nov; 76(11):1111-9. PubMed ID: 11702899
[TBL] [Abstract][Full Text] [Related]
20. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
Loke I; Squire IB; Davies JE; Ng LL
Eur J Heart Fail; 2003 Oct; 5(5):599-606. PubMed ID: 14607197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
